TSX News -
BELLUS Health Closes $35M Financing to Support Development of its Lead Drug Candidate BLU-5937 for Chronic Cough
Financing led by OrbiMed with Appointment of Mr. Chau Q. Khuong to BELLUS Board of Directors LAVAL, Quebec, Dec. 18, 2018 […]